Level Four Advisory Services LLC Decreases Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Level Four Advisory Services LLC trimmed its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,124 shares of the exchange traded fund’s stock after selling 223 shares during the period. Level Four Advisory Services LLC’s holdings in SPDR S&P Biotech ETF were worth $552,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in XBI. Mirae Asset Securities USA Inc. raised its stake in shares of SPDR S&P Biotech ETF by 66.7% in the fourth quarter. Mirae Asset Securities USA Inc. now owns 1,500,000 shares of the exchange traded fund’s stock valued at $135,090,000 after buying an additional 600,000 shares during the period. Proficio Capital Partners LLC raised its stake in SPDR S&P Biotech ETF by 16,156.1% in the 4th quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock valued at $82,615,000 after acquiring an additional 911,686 shares during the period. Raymond James Financial Inc. purchased a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at about $55,529,000. Whittier Trust Co. boosted its position in SPDR S&P Biotech ETF by 3.1% during the fourth quarter. Whittier Trust Co. now owns 320,740 shares of the exchange traded fund’s stock worth $28,885,000 after purchasing an additional 9,713 shares during the period. Finally, J.Safra Asset Management Corp increased its stake in shares of SPDR S&P Biotech ETF by 461.6% in the fourth quarter. J.Safra Asset Management Corp now owns 292,502 shares of the exchange traded fund’s stock worth $26,293,000 after purchasing an additional 240,415 shares in the last quarter.

SPDR S&P Biotech ETF Stock Down 1.3 %

NYSEARCA XBI opened at $84.40 on Monday. The company’s 50 day moving average is $89.40 and its 200-day moving average is $93.91. The firm has a market cap of $5.47 billion, a P/E ratio of 11.47 and a beta of 0.99. SPDR S&P Biotech ETF has a 12-month low of $81.14 and a 12-month high of $105.47.

SPDR S&P Biotech ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Wednesday, March 26th. Stockholders of record on Monday, March 24th were issued a $0.0053 dividend. The ex-dividend date of this dividend was Monday, March 24th.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.